4Chadwick, C & Cappelli, P. Alternatives to Generic Strategy Typologies Human Resources Management ,Research in Personal and Human Resources Management: Supplement, 1998 (4) : 1-29.
5Lado, A.A & Wilson , M.C. Human Resource System and Sustained Competitive Advantage: A ompetency-based perspective. Academy of Management Journal , 1994 (19) :699-727.
6Huselid, The Impact of Human Resource Management Practices on Turnover Productivity, and Corporate Financial Performance, Academy of Management Journal, 1995 (38):635-672.
7Pfeffer, J. Competitive Advantage Through People: Unleashing the Power of the Workforce, Boston: Harvard Business School Press, 1996.
8Michael, A. Sheppeck. Leadership, Values, and Accountability .In M. M. Chemers & , R. Ayman (Eds.) ,Leadership Theory and Research: Perspectives and Directions:109-136. San Diego , CA: academic Press , 2000.
9Ferris, G ·R· , Arthur, M · M., Berkson, H· M., kaplan, D · M., HarrellCook, G., & Frink, D·D· Toward a Social Context Theory of the Human Resource Mangagement : Organization Effectitive Relationships,Human Resource Mangagement Review 1998, 8:235 - 264.
5Andrade G, M Mitchell ,E Staford (2001). New Evidence and Perspectives on Mergers. Journal of Economic Perspectives. 15, 103-120.
6Barrett A, Capell K(2002). Big pharma: Getting too big for its own goody Business Week. July 29:74.
7Brealy R A, S C Myers (2003). Principles of Corporate Finance.Irwin, McGrow-Hill, 6th edition.
8Bruce Rasmussen(2002). The Role of Pharmaceutical Alliances. Centre for Strategic Economic Studies Victoria University of Technology: Pharmaceutical Industry Project Equity, Sustainability and Industry Development Working Paper Series. June.
9Christopher B Kummer.(2006). mergers & Acquisition in The Pharmaceutical Industry in South America:Activity and Strategic[C] Intentions.Global Confernece on Business and Finance. San Jose, Costa Rica.
10Carmine Ornaghi( 2006).Mergers and Innovation:The Case of the Pharmaceutical Industry. Discussion paper of University of Southampton: 0605.
